Pear Therapeutics Obtains $64,000,000 Series C Funding

Company Information

Company
Pear Therapeutics

Website

http://www.peartherapeutics.com

Location
200 State St. Boston, MA 02109

Description
Pear Therapeutics’ patented eFormulation approach combines mobile health apps with supplements, medical foods, and pharmaceuticals, to create more efficacious treatment solutions. eFormulations are simple to use. A software access code on the product packaging provides access to Pear’s health apps.

Transaction Details

  • Date – 1/7/2019
  • Transaction Type – Venture Equity
  • Transaction Amount – $64,000,000
  • Transaction Round – Series C
  • Acquire / Investor(s) – Temasek Holdings
  • Acquire / Investor(s) – Novartis Venture Fund
  • Acquire / Investor(s) – 5AM Ventures
  • Acquire / Investor(s) – Arboretum Ventures
  • Acquire / Investor(s) – JAZZ Venture Partners
  • Acquire / Investor(s) – Bridge Builders Collaborative
  • Acquire / Investor(s) – Edbi
  • Acquire / Investor(s) – Trustbridge Partners
  • Acquire / Investor(s) – Blue Water Life Science Fund